Literature DB >> 21745337

Etiology of a genetically complex seizure disorder in Celf4 mutant mice.

J L Wagnon1, C L Mahaffey, W Sun, Y Yang, H-T Chao, W N Frankel.   

Abstract

Mice deficient for the gene encoding the RNA-binding protein CELF4 (CUGBP, ELAV-like family member 4) have a complex seizure phenotype that includes both convulsive and non-convulsive seizures, depending upon gene dosage and strain background, modeling genetically complex epilepsy. Invertebrate CELF is associated with translational control in fruit fly ovary epithelium and with neurogenesis and neuronal function in the nematode. Mammalian CELF4 is expressed widely during early development, but is restricted to the central nervous system in adults. To better understand the etiology of the seizure disorder of Celf4 deficient mice, we studied seizure incidence with spatial and temporal conditional knockout Celf4 alleles. For convulsive seizure phenotypes, it is sufficient to delete Celf4 in adulthood at the age of 7 weeks. This timing is in contrast to absence-like non-convulsive seizures, which require deletion before the end of the first postnatal week. Interestingly, selective deletion of Celf4 from cerebral cortex and hippocampus excitatory neurons, but not from inhibitory neurons, is sufficient to lower seizure threshold and to promote spontaneous convulsions. Correspondingly, Celf4 deficient mice have altered excitatory, but not inhibitory, neurotransmission as measured by patch-clamp recordings of cortical layer V pyramidal neurons. Finally, immunostaining in conjunction with an inhibitory neuron-specific reporter shows that CELF4 is expressed predominantly in excitatory neurons. Our results suggest that CELF4 plays a specific role in regulating excitatory neurotransmission. We posit that altered excitatory neurotransmission resulting from Celf4 deficiency underlies the complex seizure disorder in Celf4 mutant mice.
© 2011 The Authors. Genes, Brain and Behavior © 2011 Blackwell Publishing Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21745337      PMCID: PMC3190060          DOI: 10.1111/j.1601-183X.2011.00717.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  50 in total

1.  Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features.

Authors:  Sergey Kalachikov; Oleg Evgrafov; Barbara Ross; Melodie Winawer; Christie Barker-Cummings; Filippo Martinelli Boneschi; Chang Choi; Pavel Morozov; Kamna Das; Elita Teplitskaya; Andrew Yu; Eftihia Cayanis; Graciela Penchaszadeh; Andreas H Kottmann; Timothy A Pedley; W Allen Hauser; Ruth Ottman; T Conrad Gilliam
Journal:  Nat Genet       Date:  2002-01-28       Impact factor: 38.330

2.  Cortical degeneration in the absence of neurotrophin signaling: dendritic retraction and neuronal loss after removal of the receptor TrkB.

Authors:  B Xu; K Zang; N L Ruff; Y A Zhang; S K McConnell; M P Stryker; L F Reichardt
Journal:  Neuron       Date:  2000-04       Impact factor: 17.173

Review 3.  Analysis of genetically complex epilepsies.

Authors:  Ruth Ottman
Journal:  Epilepsia       Date:  2005       Impact factor: 5.864

Review 4.  TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration.

Authors:  Clotilde Lagier-Tourenne; Magdalini Polymenidou; Don W Cleveland
Journal:  Hum Mol Genet       Date:  2010-04-15       Impact factor: 6.150

5.  Acquired dendritic channelopathy in temporal lobe epilepsy.

Authors:  Christophe Bernard; Anne Anderson; Albert Becker; Nicholas P Poolos; Heinz Beck; Daniel Johnston
Journal:  Science       Date:  2004-07-23       Impact factor: 47.728

6.  Fragile X syndrome: associated neurological abnormalities and developmental disabilities.

Authors:  K E Wisniewski; J H French; S Fernando; W T Brown; E C Jenkins; E Friedman; A L Hill; C M Miezejeski
Journal:  Ann Neurol       Date:  1985-12       Impact factor: 10.422

7.  Derivation of completely cell culture-derived mice from early-passage embryonic stem cells.

Authors:  A Nagy; J Rossant; R Nagy; W Abramow-Newerly; J C Roder
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism.

Authors:  Christa Lese Martin; Jacqueline A Duvall; Yesim Ilkin; Jason S Simon; M Gladys Arreaza; Kristin Wilkes; Ana Alvarez-Retuerto; Amy Whichello; Cynthia M Powell; Kathleen Rao; Edwin Cook; Daniel H Geschwind
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-10-05       Impact factor: 3.568

9.  Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.

Authors:  Hsiao-Tuan Chao; Hongmei Chen; Rodney C Samaco; Mingshan Xue; Maria Chahrour; Jong Yoo; Jeffrey L Neul; Shiaoching Gong; Hui-Chen Lu; Nathaniel Heintz; Marc Ekker; John L R Rubenstein; Jeffrey L Noebels; Christian Rosenmund; Huda Y Zoghbi
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

10.  Multiple distinct subtypes of GABAergic neurons in mouse visual cortex identified by triple immunostaining.

Authors:  Yuri Gonchar; Quanxin Wang; Andreas Burkhalter
Journal:  Front Neuroanat       Date:  2008-03-28       Impact factor: 3.856

View more
  19 in total

Review 1.  RNA protein interaction in neurons.

Authors:  Robert B Darnell
Journal:  Annu Rev Neurosci       Date:  2013-05-20       Impact factor: 12.449

2.  Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice.

Authors:  Ariadna Amador; Christopher D Bostick; Heather Olson; Jurrian Peters; Chad R Camp; Daniel Krizay; Wenjuan Chen; Wei Han; Weiting Tang; Ayla Kanber; Sukhan Kim; JiaJie Teoh; Megha Sah; Sabrina Petri; Hunki Paek; Ana Kim; Cathleen M Lutz; Mu Yang; Scott J Myers; Subhrajit Bhattacharya; Hongjie Yuan; David B Goldstein; Annapurna Poduri; Michael J Boland; Stephen F Traynelis; Wayne N Frankel
Journal:  Brain       Date:  2020-07-01       Impact factor: 13.501

3.  Haploinsufficiency of ARHGAP42 is associated with hypertension.

Authors:  Amanda S Fjorder; Malene B Rasmussen; Mana M Mehrjouy; Lusine Nazaryan-Petersen; Claus Hansen; Mads Bak; Niels Grarup; Anne Nørremølle; Lars A Larsen; Henrik Vestergaard; Torben Hansen; Niels Tommerup; Iben Bache
Journal:  Eur J Hum Genet       Date:  2019-03-21       Impact factor: 4.246

Review 4.  CELFish ways to modulate mRNA decay.

Authors:  Irina Vlasova-St Louis; Alexa M Dickson; Paul R Bohjanen; Carol J Wilusz
Journal:  Biochim Biophys Acta       Date:  2013-01-15

Review 5.  CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease.

Authors:  Andrea N Ladd
Journal:  Mol Cell Neurosci       Date:  2012-12-14       Impact factor: 4.314

6.  Deletion of the Kv2.1 delayed rectifier potassium channel leads to neuronal and behavioral hyperexcitability.

Authors:  D J Speca; G Ogata; D Mandikian; H I Bishop; S W Wiler; K Eum; H Jürgen Wenzel; E T Doisy; L Matt; K L Campi; M S Golub; J M Nerbonne; J W Hell; B C Trainor; J T Sack; P A Schwartzkroin; J S Trimmer
Journal:  Genes Brain Behav       Date:  2014-03-07       Impact factor: 3.449

Review 7.  RNA-binding proteins, neural development and the addictions.

Authors:  C D Bryant; N Yazdani
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

8.  The expression analysis of Sfrs10 and Celf4 during mouse retinal development.

Authors:  Devi Krishna Priya Karunakaran; Sean Congdon; Thomas Guerrette; Abdul Rouf Banday; Christopher Lemoine; Nisarg Chhaya; Rahul Kanadia
Journal:  Gene Expr Patterns       Date:  2013-08-07       Impact factor: 1.224

9.  Control of CNS functions by RNA-binding proteins in neurological diseases.

Authors:  Yijing Zhou; Fengping Dong; Yingwei Mao
Journal:  Curr Pharmacol Rep       Date:  2018-05-02

10.  Aberrant sodium channel activity in the complex seizure disorder of Celf4 mutant mice.

Authors:  Wenzhi Sun; Jacy L Wagnon; Connie L Mahaffey; Michael Briese; Jernej Ule; Wayne N Frankel
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.